Events & Presentations Presentations Vaxcyte June Investor Presentation VAX-24 Phase 2 Infant Study Final Results VAX-24 Phase 2 Infant Study Interim Topline Results VAX-31 Phase 1/2 Adult Study Results Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Past Events Jul 28, 2026 BTIG Virtual Biotechnology Conference Jul 15, 2026 Leerink Partners Therapeutics Forum Jun 15, 2026 11:30 AM EDT Vaxcyte, Inc. Virtual Stockholders Meeting Feb 24, 2026 4:30 PM EST Vaxcyte 4Q & FY 2025 Financial Results and Business Update Jun 12, 2025 11:30 AM EDT Vaxcyte, Inc. Virtual Stockholders Meeting Mar 31, 2025 8:00 AM EDT Vaxcyte VAX-24 Phase 2 Infant Study Results Conference Call Feb 25, 2025 4:30 PM EST Vaxcyte 4Q & FY 2024 Financial Results and Business Update Sep 3, 2024 8:00 AM EDT Vaxcyte VAX-31 Phase 1/2 Adult Study Results Conference Call Apr 17, 2023 7:30 AM EDT Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Conference Call Oct 24, 2022 8:00 AM EDT Vaxcyte VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call
Presentations Vaxcyte June Investor Presentation VAX-24 Phase 2 Infant Study Final Results VAX-24 Phase 2 Infant Study Interim Topline Results VAX-31 Phase 1/2 Adult Study Results Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Past Events Jul 28, 2026 BTIG Virtual Biotechnology Conference Jul 15, 2026 Leerink Partners Therapeutics Forum Jun 15, 2026 11:30 AM EDT Vaxcyte, Inc. Virtual Stockholders Meeting Feb 24, 2026 4:30 PM EST Vaxcyte 4Q & FY 2025 Financial Results and Business Update Jun 12, 2025 11:30 AM EDT Vaxcyte, Inc. Virtual Stockholders Meeting Mar 31, 2025 8:00 AM EDT Vaxcyte VAX-24 Phase 2 Infant Study Results Conference Call Feb 25, 2025 4:30 PM EST Vaxcyte 4Q & FY 2024 Financial Results and Business Update Sep 3, 2024 8:00 AM EDT Vaxcyte VAX-31 Phase 1/2 Adult Study Results Conference Call Apr 17, 2023 7:30 AM EDT Vaxcyte VAX-24 Phase 2 65+ Adult Study Results Conference Call Oct 24, 2022 8:00 AM EDT Vaxcyte VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call
